Agenda

Date 1: 6 May 2023

09:00 – 10:00
(CET)

Scientific Session A: New Horizon in Solid Tumors Immunotherapeutics

Immunotherapy targets in melanoma and other cancer types

Prof. Antonio Facchiano

Istituto Dermopatico dell’Immacolata, IDI-IRCCS, Roma, Italy
10:00 – 11:00
(CET)

Scientific Session B: New developments in Gastrointestinal (GI) Tumors Immunotherapeutics

GUCY2C-directed vaccines for GI cancer recurrence prevention

Prof. Adam E. Snook

Associate Director, Clinical & Translational Research Sidney Kimmel Cancer Center

Thomas Jefferson University, Philadelphia, PA, USA

11:00 – 12:00
(CET)

Scientific Session C: Covid-19 Novel Developments & Clinical Applications

Systems Immunology of COVID-19: shedding new light on unanswered questions

Dr Otavio Marques

Department of Immunology, University of São Paulo, São Paulo, Brazil

12:00 – 13:00

Lunch Break

13:00 – 14:00
(CET)

Scientific Session D: New developments in Genitourinary Tumors Immunotherapeutics

Single-cell atlases link macrophages and CD8+ T-cell in immunotherapy response in urothelial carcinoma

Prof. CI Weimin

Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China

14:00 – 15:00
(CET)

Scientific Session E: New Horizon in Immunotherapeutics

Biomarkers for Immunotherapy

Prof. Liying Zhang

David Geffen School of Medicine at UCLA,UCLA Jonsson Comprehensive Cancer Center, LA, USA

15:00 – 16:00
(CET)

Scientific Session F: Vaccination Immunobiology: New Findings & applications in oncology and other fields

Dendritic cell-derived extracellular blebs for cell-based, cell-free vaccination

Prof. YoungJik Kwon

School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, Irvine, CA, USA

16:00 – 17:00
(CET)

Scientific Session G: New Horizon in Breast Tumors Immunotherapeutics

A 3D Bioprinted Breast Cancer Model for Immunotherapy

Prof. Ibrahim Tarik Ozbolat

La Jolla Immunology Institute, San Diego, California USA

17:00 – 18:00
(CET)

Scientific Session H: New Therapeutic Solutions in Gynecological Cancers

Therapeutic Vaccines for Ovarian Cancer

Prof. Oliver Dorigo

Director, Division Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University, Stanford, California, USA

SMART Cytology in Body Fluid for Precision Management of Ovarian Cancer Patient

Prof. Jianyu Rao

Vice Chair, Department of pathology and laboratory medicine at University of California at Los Angeles, Los Angeles CA, USA

Date 2: 7 May 2023

09:00 – 10:00
(CET)

Scientific Session A: New Findings & Solutions: Immunotherapeutics in Lung & Urinary Cancers

Prognostic models for immunotherapy of lung and urology cancers incorporating the peripheral blood derived immune-inflammatory indices

Dr Giuseppe Luigi Banna

Portsmouth Hospitals University NHS Trust, Portsmouth, UK

10:00 – 11:00
(CET)

Scientific Session B: Novel Developments in Gynecological Cancer

Antibody-drug conjugates in Ovarian Cancer

Dr Gottfried E. Konecny

Division of Hematology/Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.

11:00 – 12:00
(CET)

Scientific Session C: Solid Tumors Immunotherapeutics

Epidemiology of Liver Cancer, a Population-based Case-control Study

Prof. Zuo-Feng Zhang

Chair of the Department of Epidemiology, Fielding School of Public Health, UCLA, LA, USA

An ex-vivo 3D platform to evaluate the efficacy of immunotherapy in melanoma patients

Dr Antonella Bresin

Istituto Dermopatico dell’Immacolata, Rome, Italy

12:00 – 13:00

Lunch Break

13:00 – 14:00
(CET)

Scientific Session D: Modern updates in Immuno-Oncology

Quantification of circulating tumor-derived extracellular vesicles for cancer detection and treatment monitoring

Prof. Tony Y. Hu

Weatherhead Presidential Chair in Biotechnology Innovation &

Director, Center for Intelligent Molecular Diagnostics, School of Medicine, Tulane University, New Orleans, LA, USA

14:00 – 15:00
(CET)

Scientific Session E: New Horizon in Lung & Breast Tumors Immunotherapeutics

Updates in Lung Cancer Pathology Classification and Testing Recommendations

Prof. William Dean Wallace

Keck School of Medicine of USC, Los Angeles, CA, USA

15:00 – 16:00
(CET)

Scientific Session F: Novel Developments in Infectious diseases

Clinical Applications of NGS in Infectious Diseases – the State of the Art

Prof. Shangxin Yang

UCLA Department of Pathology and Laboratory Medicine, LA, USA

16:00 – 17:00
(CET)

Scientific Session G: Tumors Immunobiology: New Findings & Solutions

Spatial Transcriptomics: Technologies, Applications and Experimental Considerations

Prof. Xinmin Li

David Geffen School of Medicine, University of California at Los Angels, LA, USA

17:00 – 18:00

Scientific Session H: Solid Tumors Immunotherapeutics

Updates on Immune biomarkers in Gastrointestinal Malignancies: Beyond Microsatellite Instability

Prof. Anwaar Saeed

University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, USA